WHO confirms a case of #polio is #Ukraine, a result of international travel from ongoing outbreak in Pakistan/Tajikistan. We are a #globalvillage and just shows how important #vaccination is everywhere until eradication is reached EndPolioNow euro.who.int/en/health-topi…

The ongoing challenge of polio, from vaccine-derived cases to better diagnostics and improved OPV outlined by Nicholas Grassly #ECCMID2022 Nick Grassly including use of nanopore sequencing to improve detection times, read more here: academic.oup.com/jid/advance-ar…

I'm pleased to share our paper reporting on oral poliovirus vaccine effectiveness in Nigeria - this work supported WHO pre-qualification of nOPV2, which was granted three weeks ago! sciencedirect.com/science/articl… Isobel Blake Ananda S Bandyopadhyay Nick Grassly Dr. Faisal Shuaib Dr Usman Adamu

Important data on safety and immunogenicity of new poliovirus vaccine in the Gambia from Drs. Magnus Ochoge and Ed Clarke - Isobel Blake and I comment on why the first nOPV2 trial in a low-income country matters and what it means for polio eradication: thelancet.com/journals/lance…

Final nOPV2 instalment from The Gambia (for now!) published in The Lancet today. Critical data which supported the licensure and WHO prequalification of this key polio eradication tool. Thanks to everyone involved here and elsewhere. sciencedirect.com/science/articl…

Welcome to #WorlImmunizationWeek2024! 💉 🎧We are kicking of the week with our first podcast with experts from Imperial College London & MRC Unit The Gambia at LSHTM discussing recent phase 3 clinical trial of the novel oral #poliovirus vaccine in The Gambia. Listen now 👉bit.ly/4aIj1zj